Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadruple regimen containing rosuvastatin for Helicobacter pylori infection
IRCT20230314057717N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rosuvastatin in Helicobacter pylori infection, sponsored by Shahid Beheshti University of Medical Sciences. Started Jul 2023; status: completed.
02
Drugs
rosuvastatin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20230314057717N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230314057717N2.